These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

978 related items for PubMed ID: 19400555

  • 21. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
    Iwasaki M, Tanaka Y, Kobayashi H, Murata-Hirai K, Miyabe H, Sugie T, Toi M, Minato N.
    Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005
    [Abstract] [Full Text] [Related]

  • 22. Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.
    von Lilienfeld-Toal M, Sievers E, Bodemüller V, Mihailescu C, Märten A, Gorschlüter M, Schmidt-Wolf IG.
    Immunol Lett; 2005 Jun 15; 99(1):103-8. PubMed ID: 15894118
    [Abstract] [Full Text] [Related]

  • 23. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
    Thedrez A, Harly C, Morice A, Salot S, Bonneville M, Scotet E.
    J Immunol; 2009 Mar 15; 182(6):3423-31. PubMed ID: 19265120
    [Abstract] [Full Text] [Related]

  • 24. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
    Kedar E, Rezai AR, Giorgi JV, Gale RP, Champlin RE, Mitsuyasu RT, Fahey JL.
    Nat Immun Cell Growth Regul; 1988 Mar 15; 7(1):13-30. PubMed ID: 2896298
    [Abstract] [Full Text] [Related]

  • 25. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
    Moens E, Brouwer M, Dimova T, Goldman M, Willems F, Vermijlen D.
    J Leukoc Biol; 2011 May 15; 89(5):743-52. PubMed ID: 21330350
    [Abstract] [Full Text] [Related]

  • 26. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
    Poccia F, Gioia C, Martini F, Sacchi A, Piacentini P, Tempestilli M, Agrati C, Amendola A, Abdeddaim A, Vlassi C, Malkovsky M, D'Offizi G.
    AIDS; 2009 Mar 13; 23(5):555-65. PubMed ID: 19238075
    [Abstract] [Full Text] [Related]

  • 27. Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.
    Thompson K, Rogers MJ.
    J Bone Miner Res; 2004 Feb 13; 19(2):278-88. PubMed ID: 14969398
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations.
    Thurman GB, Maluish AE, Rossio JL, Schlick E, Onozaki K, Talmadge JE, Procopio AD, Ortaldo JR, Ruscetti FW, Stevenson HC.
    J Biol Response Mod; 1986 Feb 13; 5(1):85-107. PubMed ID: 3514800
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S, Nagato K, Kunii N, Yamamoto H, Yamasaki K, Okita K, Hanaoka H, Shimizu N, Suzuki M, Yoshino I, Taniguchi M, Fujisawa T, Nakayama T.
    J Immunol; 2009 Feb 15; 182(4):2492-501. PubMed ID: 19201905
    [Abstract] [Full Text] [Related]

  • 34. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
    Besser MJ, Schallmach E, Oved K, Treves AJ, Markel G, Reiter Y, Schachter J.
    Cytotherapy; 2009 Feb 15; 11(2):206-17. PubMed ID: 19148842
    [Abstract] [Full Text] [Related]

  • 35. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009 Feb 15; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 36. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S.
    Oncol Rep; 2008 Jul 15; 20(1):155-63. PubMed ID: 18575732
    [Abstract] [Full Text] [Related]

  • 37. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE.
    Clin Cancer Res; 2006 Oct 01; 12(19):5850-8. PubMed ID: 17020993
    [Abstract] [Full Text] [Related]

  • 38. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP, Urban FA, Macgregor JN, Hughes DP, McDonagh KT.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [Abstract] [Full Text] [Related]

  • 39. Target cell lysis and IL-2 secretion by gamma/delta T lymphocytes after activation with bacteria.
    Munk ME, Gatrill AJ, Kaufmann SH.
    J Immunol; 1990 Oct 15; 145(8):2434-9. PubMed ID: 2145360
    [Abstract] [Full Text] [Related]

  • 40. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.
    Ohshita A, Yamaguchi Y, Minami K, Okita R, Toge T.
    Int J Oncol; 2006 May 15; 28(5):1163-71. PubMed ID: 16596232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.